GUEST COLUMNISTS

• The FDA Calls For Culturally-Informed Research, But What Do We Understand About The Sikh Community?

  Despite the size and visibility of the community — and the call for diverse patient research — there remains a gap in available health data specific to the Sikh community in the U.S.

• The Key Role Of Clinical Supply Teams In Patient Centricity Efforts

  Clinical supply decisions shape patient access, safety, and trial success. From logistics to procurement, patient-centric supply can accelerate therapies or quietly delay them.

• Pharma Procurement Can Make Or Break Startups: Let's Help Mature Our Future Partners To Secure Innovation

  To secure long-term innovation, Ascendis Pharma's Ivanna Rosendal suggests pharma companies should help startup companies through their growing pains.

• Becoming A Backbone Therapy: Lessons Learned With Actuate Therapeutics

  CEO Dan Schmitt discusses the pursuit of a backbone therapy and how Actuate's current and planned trials are structured to confirm that potential.

• Building Patient Trust In Research Through Connection Driven-Transparency

  The question is not whether trust matters but how industry, sponsors, and investigators can bridge the trust gap to drive patient participation.

• How To Lead A Moonshot Collaboration: Lessons From Over A Decade Of Competitors Working Together

  TransCelerate BioPharma's Andy Lee and Janice Change share the lessons they learned bringing disparate voices together for a united purpose.

• Patient Trust In Pharma Is Low; Here's How To Rebuild It

  CISCRP's Annick de Bruin and Shalome Sine provide strategies for building patient trust based on the findings from their Perceptions & Insights Study.

• The U.S. Trial Advantage Is Eroding

  Once the go-to location for trials, the U.S. is now seeing competition from APAC, driven by political, economic, and workforce pressures domestically and rapid growth abroad.